XML 28 R18.htm IDEA: XBRL DOCUMENT v3.22.1
Segment Reporting (Tables)
 3 Months Ended
Mar. 31, 2022
Segment Reporting [Abstract]  
Schedule of Reconciliation of Revenue from Segments to Consolidated The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment’s internal financial information as used for corporate management purposes (in thousands):
Three Months Ended March 31,
20222021
OmniAb business revenue
  Royalties$263 $— 
  Contract8,915 8,559 
Total OmniAb business revenue
9,178 8,559 
Ligand core business revenue
  Royalties13,432 7,112 
  Captisol - Core 6,226 1,253 
  Captisol - COVID5,896 30,019 
  Contract10,961 8,207 
 Total Ligand core business revenue36,515 46,591 
     Total revenue$45,693 $55,150 
Segment operating income (loss)
OmniAb business
$(6,189)$(4,604)
Ligand core business9,991 18,446 
Total segment operating income3,802 13,842 
Unallocated corporate items
Shared-based compensation5,657 4,870 
Other corporate expenses7,451 4,257 
  Total unallocated corporate items13,108 9,127 
Income (loss) from operations$(9,306)$4,715